ABSTRACT
In recent years, functional genomics approaches combining genetic information with bulk RNA-sequencing data have identified the downstream expression effects of disease-associated genetic risk factors through so-called expression quantitative trait locus (eQTL) analysis. Single-cell RNA-sequencing creates enormous opportunities for mapping eQTLs across different cell types and in dynamic processes, many of which are obscured when using bulk methods. Rapid increase in throughput and reduction in cost per cell now allow this technology to be applied to large-scale population genetics studies. To fully leverage these emerging data resources, we have founded the single-cell eQTLGen consortium (sc-eQTLGen), aimed at pinpointing the cellular contexts in which disease-causing genetic variants affect gene expression. Here, we outline the goals, approach and potential utility of the sc-eQTLGen consortium. We also provide a set of study design considerations for future single-cell eQTL studies.
Subject(s)
Gene Expression , Genetic Predisposition to Disease , Genetics, Population , Quantitative Trait Loci , Single-Cell Analysis , Gene Regulatory Networks , Genotype , Humans , Polymorphism, Single Nucleotide , RNA-Seq , Sequence Analysis, RNASubject(s)
Peptidyl-Dipeptidase A/genetics , Peptidyl-Dipeptidase A/metabolism , Severe Acute Respiratory Syndrome/virology , Severe acute respiratory syndrome-related coronavirus/pathogenicity , Vesiculovirus/pathogenicity , Virus Attachment , Angiotensin-Converting Enzyme 2 , Animals , Cats , Cells, Cultured , Chickens , Chinchilla , Chiroptera , Cricetinae , Disease Susceptibility/virology , Dogs , Genetic Vectors , Guinea Pigs , Host Specificity , Humans , Membrane Glycoproteins/metabolism , Membrane Proteins/metabolism , Mesocricetus , Mice , Phodopus , Rabbits , Rats , Rats, Sprague-Dawley , Severe acute respiratory syndrome-related coronavirus/physiology , Sequence Analysis, DNA , Severe Acute Respiratory Syndrome/transmission , Spike Glycoprotein, Coronavirus , Sus scrofa , Vesiculovirus/physiology , Viral Envelope Proteins/metabolism , ViverridaeABSTRACT
1. The adenovirus-mediated overexpression of SARS coronavirus (SARS-CoV) spike protein (S) and its C-terminal domain (S2) induce apoptosis in Vero E6 cells. 2. Such apoptosis in Vero E6 cells is time- and dose-dependent. 3. The adenovirus-mediated overexpression of SARS-CoV N-terminal domain (S1) and other structural proteins, including E,M and N protein, do not induce apoptosis.
Subject(s)
Adenoviridae/metabolism , Apoptosis/genetics , Gene Expression Regulation, Viral , Severe Acute Respiratory Syndrome/virology , Severe acute respiratory syndrome-related coronavirus/genetics , Adenoviridae/genetics , Animals , Apoptosis/physiology , Cell Death/genetics , Cell Proliferation , Cells, Cultured , Chlorocebus aethiops , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Probability , Severe acute respiratory syndrome-related coronavirus/physiology , Sensitivity and Specificity , Severe Acute Respiratory Syndrome/genetics , Spike Glycoprotein, Coronavirus , Transduction, Genetic , Vero Cells/cytology , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism , Viral Structural Proteins/genetics , Viral Structural Proteins/metabolismSubject(s)
Severe Acute Respiratory Syndrome/epidemiology , Antibodies, Viral/analysis , Blotting, Western , Coronavirus/immunology , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Enzyme-Linked Immunosorbent Assay , Hong Kong/epidemiology , Humans , Membrane Glycoproteins/immunology , Nucleocapsid Proteins/immunology , Severe acute respiratory syndrome-related coronavirus/immunology , Severe acute respiratory syndrome-related coronavirus/isolation & purification , Seroepidemiologic Studies , Severe Acute Respiratory Syndrome/diagnosis , Spike Glycoprotein, Coronavirus , Viral Envelope Proteins/immunologyABSTRACT
BACKGROUND: Severe acute respiratory syndrome (SARS) is a newly emerged disease caused by a novel coronavirus (SARS-CoV), which spread globally in early 2003, affecting over 30 countries. We have used molecular epidemiology to define the patterns of spread of the virus in Hong Kong and beyond. METHODS: The case definition of SARS was based on that recommended by WHO. We genetically sequenced the gene for the S1 unit of the viral spike protein of viruses from patients with SARS in Hong Kong (138) and Guangdong (three) in February to April, 2003. We undertook phylogenetic comparisons with 27 other sequences available from public databases (Genbank). FINDINGS: Most of the Hong Kong viruses (139/142), including those from a large outbreak in an apartment block, clustered closely together with the isolate from a single index case (HKU-33) who came from Guangdong to Hong Kong in late February. Three other isolates were genetically distinct from HKU-33 in Hong Kong during February, but none of these contributed substantially to the subsequent local outbreak. Viruses identified in Guangdong and Beijing were genetically more diverse. INTERPRETATION: The molecular epidemiological evidence suggests that most SARS-CoV from the outbreak in Hong Kong, as well as the viruses from Canada, Vietnam, and Singapore, are genetically closely linked. Three viruses found in Hong Kong in February were phylogenetically distinct from the major cluster, which suggests that several introductions of the virus had occurred, but that only one was associated with the subsequent outbreak in Hong Kong, which in turn spread globally.
Subject(s)
Severe Acute Respiratory Syndrome/epidemiology , Severe acute respiratory syndrome-related coronavirus/genetics , Canada/epidemiology , Databases, Nucleic Acid/statistics & numerical data , Disease Outbreaks/statistics & numerical data , Genome, Viral , Hong Kong/epidemiology , Humans , Molecular Epidemiology , Nucleic Acid Amplification Techniques/methods , RNA, Viral/genetics , Severe Acute Respiratory Syndrome/transmission , Severe Acute Respiratory Syndrome/virology , Singapore/epidemiology , Vietnam/epidemiologyABSTRACT
The main objective of this paper is to review the chemical and genetic methods used in authentication of ginseng, especially the recent advances in microsatellite genotyping and its application to the authentication of other traditional Chinese medicines (TCM). The standardization and modernization of TCM hinge on the authentication of their botanical identities. Analysis of well-characterized marker compounds is now the most popular method for identifying the herbal materials and quality control of TCM, eg, ginsenoside profiling for authentication of Panax species. However, in many herbal species the chemical composition of the plant changes with the external environment and processing conditions, which lowers the reliability of these authentication methods. In the light of the advances in molecular biotechnology in the past few decades, genetic tools are now considered to provide more standardized and reliable methods for authentication of herbal materials at the DNA level. These genetic tools include random amplified polymorphic DNA (RAPD), DNA fingerprinting using multi-loci probes, restriction fragment length polymorphism (RFLP), amplified fragment length polymorphism (AFLP), and microsatellite marker technology. The practicality of these methods varies in terms of their sensitivity, reliability, reproducibility, and running cost. Using ginseng as an example, we reviewed the advantages and limitations of these molecular techniques in TCM authentication. We have developed a set of microsatellite markers from American ginseng that are able to differentiate Panax ginseng and Panax quinquetolius with the resolution down to farm level, ie, confirmation of its botanical identity and origin. Compared with other molecular techniques, microsatellite marker technology is more robust, accurate, reproducible, reliable, and sensitive. This is essential for large-scale TCM authentication centers.
Subject(s)
Microsatellite Repeats , Panax/genetics , Plants, Medicinal/genetics , DNA Fingerprinting , Panax/chemistry , Panax/classification , Plants, Medicinal/chemistry , Polymorphism, Restriction Fragment Length , Quality ControlABSTRACT
The complete genomic nucleotide sequence (29.7kb) of a Hong Kong severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) strain HK-39 is determined. Phylogenetic analysis of the genomic sequence reveals it to be a distinct member of the Coronaviridae family. 5' RACE assay confirms the presence of at least six subgenomic transcripts all containing the predicted intergenic sequences. Five open reading frames (ORFs), namely ORF1a, 1b, S, M, and N, are found to be homologues to other CoV members, and three more unknown ORFs (X1, X2, and X3) are unparalleled in all other known CoV species. Optimal alignment and computer analysis of the homologous ORFs has predicted the characteristic structural and functional domains on the putative genes. The overall nucleotides conservation of the homologous ORFs is low (<5%) compared with other known CoVs, implying that HK-39 is a newly emergent SARS-CoV phylogenetically distant from other known members. SimPlot analysis supports this finding, and also suggests that this novel virus is not a product of a recent recombinant from any of the known characterized CoVs. Together, these results confirm that HK-39 is a novel and distinct member of the Coronaviridae family, with unknown origin. The completion of the genomic sequence of the virus will assist in tracing its origin.